Covaxin trials in children between 2 and 18 years to begin in 10-12 days, says Niti Aayog member

Niti Aayog Member (Health) Dr. VK Paul said that the Phase 2-3 clinical trials of COVID-19 vaccine, Covaxin for in the age group of 2 to 18 years will begin in the next 10-12 days.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting